| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1248.204 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.204/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204 |
| Version | 20240604 |
| Status | active |
| Date | 2024-06-04T01:21:19-04:00 |
| Name | VTEProphylaxis |
| Title | VTE Prophylaxis |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for medications for venous thromboembolism (VTE) prophylaxis.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent injectable and oral medications considered to be VTE prophylaxis medications.),(Exclusion Criteria: No exclusions) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
| ValueSet | |
| 2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis |
| 2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors |
| 2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis |
| 2.16.840.1.113883.3.117.1.7.1.134 | Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment |
| 2.16.840.1.113883.3.117.1.7.1.205 | Direct Thrombin Inhibitor |
| 2.16.840.1.113883.3.117.1.7.1.211 | Injectable Factor Xa Inhibitor for VTE Prophylaxis |
| 2.16.840.1.113883.3.117.1.7.1.218 | Unfractionated Heparin |
| 2.16.840.1.113883.3.117.1.7.1.219 | Low Molecular Weight Heparin for VTE Prophylaxis |
| 2.16.840.1.113883.3.117.1.7.1.232 | Warfarin |
No narrative content found in resource
FHIR